FR2643263B1 - Composition pharmaceutique a base de ranitidine - Google Patents

Composition pharmaceutique a base de ranitidine

Info

Publication number
FR2643263B1
FR2643263B1 FR909002187A FR9002187A FR2643263B1 FR 2643263 B1 FR2643263 B1 FR 2643263B1 FR 909002187 A FR909002187 A FR 909002187A FR 9002187 A FR9002187 A FR 9002187A FR 2643263 B1 FR2643263 B1 FR 2643263B1
Authority
FR
France
Prior art keywords
ranitidine
pharmaceutical composition
composition based
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR909002187A
Other languages
English (en)
French (fr)
Other versions
FR2643263A1 (fr
Inventor
Chopra Sham Kumar
Makadia Tarun Tribhovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Inc
Original Assignee
Glaxo Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Canada Inc filed Critical Glaxo Canada Inc
Publication of FR2643263A1 publication Critical patent/FR2643263A1/fr
Application granted granted Critical
Publication of FR2643263B1 publication Critical patent/FR2643263B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR909002187A 1989-02-23 1990-02-22 Composition pharmaceutique a base de ranitidine Expired - Lifetime FR2643263B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898904182A GB8904182D0 (en) 1989-02-23 1989-02-23 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FR2643263A1 FR2643263A1 (fr) 1990-08-24
FR2643263B1 true FR2643263B1 (fr) 1994-09-16

Family

ID=10652220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR909002187A Expired - Lifetime FR2643263B1 (fr) 1989-02-23 1990-02-22 Composition pharmaceutique a base de ranitidine

Country Status (26)

Country Link
US (1) US5028432A (enExample)
JP (1) JP2856817B2 (enExample)
KR (1) KR940006271B1 (enExample)
AT (1) AT401727B (enExample)
AU (1) AU629303B2 (enExample)
BE (1) BE1003123A3 (enExample)
CA (1) CA2010692C (enExample)
CH (1) CH680567A5 (enExample)
CY (1) CY1734A (enExample)
DE (1) DE4005650C2 (enExample)
DK (1) DK170209B1 (enExample)
FR (1) FR2643263B1 (enExample)
GB (2) GB8904182D0 (enExample)
HK (1) HK89493A (enExample)
HU (1) HU211930A9 (enExample)
IE (1) IE63179B1 (enExample)
IL (1) IL93490A (enExample)
IT (1) IT1240768B (enExample)
LU (1) LU87681A1 (enExample)
NL (1) NL193267C (enExample)
NZ (1) NZ232642A (enExample)
PH (1) PH26972A (enExample)
SA (1) SA90100287B1 (enExample)
SE (1) SE512412C2 (enExample)
ZA (1) ZA901348B (enExample)
ZW (1) ZW1790A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992004893A1 (en) * 1990-09-13 1992-04-02 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9705813D0 (en) * 1997-03-20 1997-05-07 Smithkline Beecham Plc Novel compositions
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
WO2003055468A1 (en) * 2001-12-21 2003-07-10 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
US7423004B2 (en) * 2003-01-31 2008-09-09 Smithkline Beecham Corporation Solid dispersion compositions
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
CA2800475C (en) 2010-06-23 2015-11-03 Colgate-Palmolive Company Therapeutic oral compositions
WO2012087279A1 (en) 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
PH12013501078A1 (en) 2010-12-20 2018-03-21 Colgate Palmolive Co Gelatin encapsulated oral care composition containing hydrophilic active hydrophobic structuring agent and oil carrier
MX336911B (es) 2010-12-20 2016-02-02 Colgate Palmolive Co Composicion para el cuidado oral no acuosa que contiene activos de oclusion dental.
RU2761346C2 (ru) * 2016-11-01 2021-12-07 Джонсон энд Джонсон Консьюмер Инк. Жидкая пероральная фармацевтическая лекарственная форма, содержащая антагонист h2-рецептора гистамина и антацид
CN109010303B (zh) * 2017-06-09 2021-05-07 苏州科伦药物研究有限公司 一种盐酸雷尼替丁胶囊的工业制备方法
KR102108153B1 (ko) * 2017-07-05 2020-05-07 (주)동구바이오제약 생체 이용률 및 안정성이 개선된 레티노이드를 함유하는 약제학적 조성물
US20210308062A1 (en) * 2018-09-07 2021-10-07 R.P. Scherer Technologies, Llc Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2360796B2 (de) * 1973-12-06 1977-06-02 Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IT1090703B (it) * 1976-12-03 1985-06-26 Scherer Ltd R P Perfezionamento nelle composizioni utili quali veicolo per farmaci
JPS5919524B2 (ja) * 1976-12-17 1984-05-07 中外製薬株式会社 安定な１α−ヒドロキシビタミンＤ類含有製剤
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) * 1979-04-11 1980-10-23 Sumitomo Chem Co Ltd Diazepam oily drug
EP0040489A1 (en) * 1980-05-17 1981-11-25 FISONS plc Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
GB2084580B (en) * 1980-10-01 1984-07-04 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
JPS58174308A (ja) * 1982-04-06 1983-10-13 Fujimoto Seiyaku Kk レクタルカプセル坐剤
SE8302689L (sv) * 1982-05-14 1983-11-15 Richter Gedeon Vegyeszet Farmaceutiska kompositioner innehallande flera aktiva bestandsdelar
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
EP0152432B1 (en) * 1983-08-01 1989-03-01 R.P. Scherer Corporation Sustained release method and product
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
GB8426738D0 (en) * 1984-10-23 1984-11-28 Scras Pyridine derivatives
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
JPH07549B2 (ja) * 1986-07-03 1995-01-11 ゼリア新薬工業株式会社 軟カプセル充填用組成物
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
CA1327748C (en) * 1988-09-20 1994-03-15 Christopher William Quirk Pharmaceutical composition containing ranitidine and alginic acid

Also Published As

Publication number Publication date
NL193267C (nl) 1999-05-06
ZW1790A1 (en) 1991-10-16
AT401727B (de) 1996-11-25
JP2856817B2 (ja) 1999-02-10
BE1003123A3 (fr) 1991-12-03
PH26972A (en) 1992-12-28
IE63179B1 (en) 1995-03-22
DK170209B1 (da) 1995-06-19
IE900651L (en) 1990-08-23
NZ232642A (en) 1992-07-28
DK48090A (da) 1990-08-24
HU211930A9 (en) 1996-01-29
CA2010692C (en) 1995-12-12
FR2643263A1 (fr) 1990-08-24
JPH03200728A (ja) 1991-09-02
IT9047659A1 (it) 1991-08-22
KR940006271B1 (ko) 1994-07-14
ATA42190A (de) 1996-04-15
DK48090D0 (da) 1990-02-22
SA90100287B1 (ar) 1999-08-15
IL93490A0 (en) 1990-11-29
AU5007390A (en) 1990-08-30
KR900012612A (ko) 1990-09-01
CA2010692A1 (en) 1990-08-23
SE9000625D0 (sv) 1990-02-22
SE9000625L (sv) 1990-08-24
GB2229094A (en) 1990-09-19
DE4005650A1 (de) 1990-09-06
GB8904182D0 (en) 1989-04-05
CH680567A5 (enExample) 1992-09-30
US5028432A (en) 1991-07-02
GB2229094B (en) 1993-01-06
CY1734A (en) 1994-05-06
HK89493A (en) 1993-09-03
DE4005650C2 (de) 1999-03-25
NL193267B (nl) 1999-01-04
SE512412C2 (sv) 2000-03-13
NL9000428A (nl) 1990-09-17
IT9047659A0 (it) 1990-02-22
LU87681A1 (fr) 1991-10-08
GB9004016D0 (en) 1990-04-18
AU629303B2 (en) 1992-10-01
ZA901348B (en) 1991-03-27
IT1240768B (it) 1993-12-17
IL93490A (en) 1994-07-31

Similar Documents

Publication Publication Date Title
FR2643263B1 (fr) Composition pharmaceutique a base de ranitidine
FI922364A7 (fi) Farmaseuttiset koostumukset
FI901102A7 (fi) Farmaseuttiset koostumukset
FI920026A7 (fi) Laihdutuslääkkeenä käyttökelpoinen farmaseuttinen koostumus
IT1240765B (it) Composizioni farmaceutiche a base di ciclosporine.
FR2633181B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
FI920646A7 (fi) Farmaseuttiset aineet
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DE69031742D1 (de) Verschachteltes Druckverfahren
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
IT1243398B (it) Composizioni di sostanze a base di dichetopirrolopirroli
BG91785A (bg) Лекарствена форма
IT8920486A0 (it) Composizioni farmaceutiche.
IT1216822B (it) Composizioni farmaceutiche a basedi chetotifene
FI893643A7 (fi) Farmaseuttisia koostumuksia
FR2645022B1 (fr) Compositions therapeutiques a base de derives de la thieno-triazolo-diazepine
BR9002396A (pt) Composicao estabilizada a base de 3-isotiazolonas
FR2638640B1 (fr) Solution pharmaceutique
FR2634125B1 (fr) Composition pharmaceutique a base de superoxyde dismutase
FR2598617B1 (fr) Composition pharmaceutique
BR9006025A (pt) Preparacao farmaceutica
FR2676364B1 (fr) Composition pharmaceutique a base de derives d'aminobutanone.
FR2594334B1 (fr) Composition pharmaceutique injectable a base d'amoxicilline
FR2648710B1 (fr) Composition pharmaceutique a base de ranitidine et son procede de preparation
DE69003003D1 (de) Pharmazeutische Zusammensetzung.